Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-24

Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating adipose-derived stem cells for chronic obstructive pulmonary disease was withdrawn; no results are reported and the sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: WITHDRAWN